64,463 Shares in HCA Healthcare, Inc. $HCA Purchased by Public Employees Retirement System of Ohio

Posted by Stanley Muller on Aug 30th, 2026

Public Employees Retirement System of Ohio bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the second quarter, HoldingsChannel reports. The institutional investor bought 64,463 shares of the company’s stock, valued at approximately $25,133,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of HCA. Sumitomo Life Insurance Co. grew its holdings in HCA Healthcare by 1.0% during the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after acquiring an additional 20 shares during the period. MJP Associates Inc. ADV grew its stake in shares of HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after purchasing an additional 21 shares during the period. Cary Street Partners Investment Advisory LLC lifted its stake in HCA Healthcare by 7.5% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after buying an additional 21 shares during the period. Anchyra Partners LLC increased its stake in shares of HCA Healthcare by 3.7% in the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after acquiring an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd boosted its stake in HCA Healthcare by 0.6% during the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after acquiring an additional 22 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $417.57 on Friday. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52. The business’s 50 day simple moving average is $401.08 and its 200 day simple moving average is $441.46. The firm has a market cap of $90.40 billion, a PE ratio of 13.98, a P/E/G ratio of 1.45 and a beta of 1.10.

HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. During the same period last year, the business earned $6.84 EPS. The business’s quarterly revenue was up 8.7% on a year-over-year basis. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio is currently 10.45%.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of recent analyst reports. The Goldman Sachs Group lowered their price objective on shares of HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a research report on Tuesday, July 28th. Deutsche Bank Aktiengesellschaft set a $476.00 price target on HCA Healthcare in a report on Monday, July 27th. Wells Fargo & Company boosted their price objective on HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a research report on Monday, August 3rd. Barclays dropped their target price on shares of HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a report on Monday, July 27th. Finally, Robert W. Baird lowered their price objective on shares of HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating for the company in a research report on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $462.64.

View Our Latest Research Report on HCA Healthcare

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.